References
- Grzelak T, Dutkiewicz A, Paszynska E, Dmitrzak-Weglarz M, Slopien A, Tyszkiewicz-Nwafor M. Neurobiochemical and psychological factors influencing the eating behaviors and attitudes in anorexia nervosa. J Physiol Biochem. 2017;73:297–305. doi: https://doi.org/10.1007/s13105-016-0540-2
- Tortorella A, Brambilla F, Fabrazzo M, Volpe U, Monteleone AM, Mastromo D, Monteleone P. Central and peripheral peptides regulating eating behavior and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review. Eur Eat Disord Rev. 2014;22:307–20. doi: https://doi.org/10.1002/erv.2303
- Yoshimura M, Uezono Y, Ueta Y. Anorexia in human and experimental animal models: physiological aspects related to neuropeptides. J Physiol Sci. 2015;65:385–95. doi: https://doi.org/10.1007/s12576-015-0386-3
- Tyszkiewicz-Nwafor M, Slopien A, Dmitrzak-Węglarz M, Rybakowski F. Adiponectin and resistin in acutely ill and weight-recovered adolescent anorexia nervosa: association with psychiatric symptoms. World J Biol Psychiatry. 2018;28:1–9.
- Dmitrzak-Weglarz M, Skibinska M, Slopien A, Tyszkiewicz M, Pawlak J, Maciukiewicz M, et al. Serum neurotrophin concentrations in polish adolescent girls with anorexia nervosa. Neuropsychobiology. 2013;67:25–32. doi: https://doi.org/10.1159/000343500
- Miljic D, Pekic S, Djurovic M, Doknic M, Milic N, Casanueva FF, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab. 2006;91:1491–5. doi: https://doi.org/10.1210/jc.2005-2304
- Leppanen J, Ng KW, Tchanturia K, Treasure J. Meta-analysis of the effects of intranasal oxytocin on interpretation and expression of emotions. Neurosci Biobehav Rev. 2017;78:125–44. doi: https://doi.org/10.1016/j.neubiorev.2017.04.010
- Stein LM, Haddock CJ, Samson WK, Kolar GR, Yosten GLC. The phoenixins: from discovery of the hormone to identification of the receptor and potential physiologic actions. Peptides. 2018;106:45–8. doi: https://doi.org/10.1016/j.peptides.2018.06.005
- Prinz P, Scharner S, Friedrich T, Schalla M, Goebel-Stengel M, Rose M, Stengel A. Central and peripheral expression sites of phoenixin-14 immunoreactivity in rats. Biochem Biophys Res Commun. 2017;1:195–201. doi: https://doi.org/10.1016/j.bbrc.2017.09.048
- Schalla MA, Stengel A. Phoenixin-A pleiotropic Gut-brain peptide. Int J Mol Sci. 2018;11:19.
- Schalla MA, Stengel A. The role of ghrelin in anorexia nervosa. J Mol Sci. 2018;19:2117. doi: https://doi.org/10.3390/ijms19072117
- Yuan T, Sun Z, Zhao W, Wang T, Zhang J, Niu D. Phoenixin: A newly discovered peptide with Multi-functions. Protein Pept Lett. 2017;24:472–5. doi: https://doi.org/10.2174/0929866524666170207154417
- Kim DK, Yun S, Son GH, Hwang JI, Park CR, Kim JI, et al. Coevolution of the spexin/galanin/kisspeptin family: spexin activates galanin receptor type II and III. Endocrinology. 2014;155:1864–73. doi: https://doi.org/10.1210/en.2013-2106
- Porzionato A, Rucinski M, Macchi V, Stecco C, Malendowicz LK, De Caro R. Spexin expression in normal rat tissues. J Histochem Cytochem. 2010;58:825–37. doi: https://doi.org/10.1369/jhc.2010.956300
- Ma A, Bai J, He M, Wong AOL. Spexin as a neuroendocrine signal with emerging functions. Gen Comp Endocrinol. 2018;265:90–6. doi: https://doi.org/10.1016/j.ygcen.2018.01.015
- Walewski JL, Ge F, Lobdell H, Levin N, Schwartz GJ, Vasselli JR, et al. Spexin is a novel human peptide that reduces adipocyte uptake of long-chain fatty acids and causes weight loss in rodents with diet-induced obesity. Obesity. 2014;22:1643–52. doi: https://doi.org/10.1002/oby.20725
- Swanson CJ, Blackburn TP, Zhang X, Zheng K, Xu ZQ, Hökfelt T, et al. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A. 2005;48:17489–94. doi: https://doi.org/10.1073/pnas.0508970102
- Pałasz A, Suszka-Świtek A, Filipczyk Ł, Bogus K, Rojczyk E, Worthington J, et al. Escitalopram affects spexin expression in the rat hypothalamus, hippocampus and striatum. Pharmacol Rep. 2016;68:1326–31. doi: https://doi.org/10.1016/j.pharep.2016.09.002
- Lv SY, Zhou YC, Zhang XM, Chen WD, Wang YD. Emerging Roles of NPQ/spexin in physiology and Pathology. Front Pharmacol. 2019;201910:457. doi: https://doi.org/10.3389/fphar.2019.00457
- Dudek M, Ziarniak K, Sliwowska JH. Kisspeptin and metabolism: The brain and Beyond. Front Endocrinol. 2018;9:145. doi: https://doi.org/10.3389/fendo.2018.00145
- Quaynor S, Hu L, Leung PK, Feng H, Mores N, Krsmanovic LZ, Catt KJ. Expression of a functional g protein-coupled receptor 54-kisspeptin autoregulatory system in hypothalamic gonadotropin-releasing hormone neurons. Mol Endocrinol. 2007;21:3062–70. doi: https://doi.org/10.1210/me.2007-0207
- Hrabovszky E. Neuroanatomy of the human hypothalamic kisspeptin system. Neuroendocrinology. 2014;99:33–48. doi: https://doi.org/10.1159/000356903
- Fu LY, Acuna-Goycolea C, van den Pol AN. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci. 2004;24:8741–51. doi: https://doi.org/10.1523/JNEUROSCI.2268-04.2004
- Stengel A, Wang L, Goebel-Stengel M, Taché Y. Centrally injected kisspeptin reduces food intake by increasing meal intervals in mice. Neuroreport. 2011;22:253–37. doi: https://doi.org/10.1097/WNR.0b013e32834558df
- De Bond JA, Smith JT. Kisspeptin and energy balance in reproduction. Reproduction. 2014;147:R53–63. doi: https://doi.org/10.1530/REP-13-0509
- Tanaka M, Csabafi K, Telegdy G. Neurotransmissions of antidepressant-like effects of kisspeptin-13. Regul Pept. 2013;180:1–4. doi: https://doi.org/10.1016/j.regpep.2012.08.017
- Lin CY, Huang T, Zhao L, Zhong LLD, Lam WC, Fan BM, Bian ZX. Circulating spexin levels negatively correlate with age, BMI, fasting glucose, and triglycerides in healthy adult women. J Endocr Soc. 2018;2:409–19. doi: https://doi.org/10.1210/js.2018-00020
- Pałasz A, Janas-Kozik M, Borrow A, Arias-Carrión O, Worthington JJ. The potential role of the novel hypothalamic neuropeptides nesfatin-1, phoenixin, spexin and kisspeptin in the pathogenesis of anxiety and anorexia nervosa. Neurochem Int. 2018;113:120–36. doi: https://doi.org/10.1016/j.neuint.2017.12.006
- Bacopoulou F, Lambrou GI, Rodanaki ME, Stergioti E, Efthymiou V, Deligeoroglou E, Markantonis SL. Serum kisspeptin concentrations are negatively correlated with body mass index in adolescents with anorexia nervosa and amenorrhea. Hormones (Athens). 2017;16:33–41.
- Kułaga Z, Litwin M, Tkaczyk M, Palczewska I, Zajączkowska M, Zwolińska D, et al. Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr. 2011;170:599–609. doi: https://doi.org/10.1007/s00431-010-1329-x
- Garner DM, Garfinkel PE. The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med. 1979;9:273–9. doi: https://doi.org/10.1017/S0033291700030762
- Beck AT, Steer RA, Garbin MG J. Psychometric properties of the Beck depression inventory Twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100. doi: https://doi.org/10.1016/0272-7358(88)90050-5
- GoodmanWK PL, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale–brown obsessive–compulsive scale. I. development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–11. doi: https://doi.org/10.1001/archpsyc.1989.01810110048007
- Janas-Kozik M, Stachowiak E. Obsessive-compulsive, depressive and anxiety symptptoms in patients with anorexia nervosa. A proposed understanding in the adolescent perspective. Psychotherapy. 2008;146:35–60.
- Kezelman S, Touyz S, Hunt C, Rhodes P. Does anxiety improve during weight restoration in anorexia nervosa? A systematic review. J Eat Disord. Mar. 2015;18(3):7. doi: https://doi.org/10.1186/s40337-015-0046-2
- Wild B, Stadnitski T, Wesche D, Stroe-Kunold E, Schultz JH, Rudofsky G, et al. Temporal relationships between awakening cortisol and psychosocial variables in inpatients with anorexia nervosa – A time series approach. Int J Psychophysiol. 2016;102:25–32. doi: https://doi.org/10.1016/j.ijpsycho.2016.03.002
- Janas-Kozik M, Stachowicz M, Krupka-Matuszczyk I, Szymszal J, Krysta K, Janas A, Rybakowski J. Plasma levels of leptin and orexin A in the restrictive type of anorexia nervosa. Regul Pept. 2011;168:5–9. doi: https://doi.org/10.1016/j.regpep.2011.02.005
- Billert M, Wojciechowicz T, Jasaszwili M, Szczepankiewicz D, Waśko J, Kaźmierczak S, et al. Phoenixin-14 stimulates differentiation of 3T3-L1 preadipocytes via cAMP/epac-dependent mechanism. Biochim Biophys Acta Mol Cell BiolLipids. 2018;1863:1449–57. doi: https://doi.org/10.1016/j.bbalip.2018.09.006
- Rocca C, Scavello F, Granieri MC, Pasqua T, Amodio N, Imbrogno S, et al. Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection. Cell Mol Life Sci. 2018;75:743–56. doi: https://doi.org/10.1007/s00018-017-2661-3
- Jiang JH, He Z, Peng YL, Jin WD, Mu J, Xue HX, et al. Effects of phoenixin-14 on anxiolytic-like behavior in mice. Behav Brain Res. 2015;286:39–48. doi: https://doi.org/10.1016/j.bbr.2015.02.011
- Hofmann T, Weibert E, Ahnis A, Elbelt U, Rose M, Klapp BF, Stengel A. Phoenixin is negatively associated with anxiety in obese men. Peptides. 2017;88:32–36. doi: https://doi.org/10.1016/j.peptides.2016.12.011
- Ullah K, Ur Rahman T, Wu DD, Lin XH, Liu Y, Guo XY, et al. Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome. Clin Chim Acta. 2017;471:243–7. doi: https://doi.org/10.1016/j.cca.2017.06.013
- Walewski JL, Ge F, Lobdell H, Levin N, Schwartz GJ, Vasselli JR, et al. Spexin is a novel human peptide that reduces adipocyte uptake oflong-chain fatty acids and causes weight loss in rodents with diet-induced obesity. Obesity. 2014;22:1643–52. doi: https://doi.org/10.1002/oby.20725
- Kumar S, Hossain J, Nader N, Aguirre R, Sriram S, Balagopal PB. Decreased circulating levels of spexin in obese children. J Clin Endocrinol Metab. 2016;7:2931–6. doi: https://doi.org/10.1210/jc.2016-1177
- Kumar S, Hossain MJ, Inge T, Balagopal PB. Roux-en-Y gastric bypass surgery in youth with severe obesity: 1-year longitudinal changes in spexin. Surg Obes Relat Dis. 2018;10:1537–43. doi: https://doi.org/10.1016/j.soard.2018.07.007
- Kołodziejski PA, Pruszyńska-Oszmałek E, Korek E, Sassek M, Szczepankiewicz D, Kaczmarek P, et al. Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women. Physiol Res. 2018;67:45–56. doi: https://doi.org/10.33549/physiolres.933467
- Yun S, Reyes-Alcaraz A, Lee YN, Yong HJ, Choi J, Ham BJ, et al. Spexin-Based galanin receptor type 2 agonist for comorbid mood disorders and abnormal body weight. Front Neurosci. 2019 Apr 18;13:391. doi: https://doi.org/10.3389/fnins.2019.00391
- Hofmann T, Elbelt U, Haas V, Ahnis A, Klapp BF, Rose M, Stengel A. Plasma kisspeptin and ghrelin levels are independently correlated with physical activity in patients with anorexia nervosa. Appetite. 2017;108:141–50. doi: https://doi.org/10.1016/j.appet.2016.09.032